[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.179.232. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1969

Prevention of Invasive Pseudomonas Infection in Burns With a New Vaccine

Author Affiliations

Detroit; Cincinnati
From the Department of Surgery, University of Cincinnati Medical Center, and the Cincinnati Shriners' Burns Institute, Cincinnati (Drs. Alexander, MacMillan, and Altemeier), and the Division of Medical and Scientific Affairs Parke-Davis & Company, Detroit (Dr. Fisher).

Arch Surg. 1969;99(2):249-256. doi:10.1001/archsurg.1969.01340140121018
Abstract

Infection continues to be the major cause of death in patients who have been severely burned although the spectrum of pathogenic bacteria responsible for the death of burned patients has undergone a definite metamorphosis.1 Prior to the discovery and use of penicillin, streptococcal infections accounted for a large number of infectious deaths. Staphylococcus aureus became the predominant cause of postburn septic deaths with the emergence of penicillin-resistant strains. In more recent years, the Staphylococcus has been controlled by penicillinase-resistant antibiotics, and infections with gram-negative organisms, especially Pseudomonas aeruginosa, have become increasingly prevalent. Most of these infections can be controlled by appropriate systemic and topical antimicrobial therapy, but sepsis from P aeruginosa continues to be a major problem in most burn centers. Well-established Pseudomonas sepsis in patients with large burns has been exceedingly difficult to control by any treatment regimen, and the vast majority of these patients fail to survive.

First Page Preview View Large
First page PDF preview
First page PDF preview
×